SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the ...
If you or someone you know has a condition called chronic spontaneous urticaria (CSU), you may have heard about Xolair. In 2014, Xolair became the first medicine to be approved for treating this ...
Self-administration does not, at least for now, entirely eliminate the role of health care providers in ensuring safe and effective vaccination. The Food and Drug Administration’s (FDA) recent ...
What are the key questions that drug delivery developers should ask when developing drugs for folks treating chronic diseases or illnesses? The first question a company should be asking themselves is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results